Search

You searched for "Breathing"

2890 results found

3D printing and sustainability in audiology and ENT

3 November 2023 | | ENTA - Audiology - Adult
As we try to avoid disposing of equipment that is still functional, we are challenged by company policies that make equipment ‘obsolete’ and no longer supported for repairs. One innovative solution is provided by 3D printing parts that are needed...
American Journal of Rhinology & Allergy cover image.

A new hope for post-COVID olfactory loss?

10 March 2023 | | ENTA - Rhinology / Sinus, ENTA - Maxillofacial Surgery
Does anyone remember COVID? It seems that what happened between 2019 and 2021 is all but forgotten about. Aside from it cropping up on news feeds occasionally and a few out-of-date automated phone messages that start off with ‘During the...

In conversation with Ray Clarke: Scott-Brown – The Editors’ view…

1 July 2018 | | ENTA - ENT
Ray Clarke. How did you get involved in the forthcoming Scott-Brown ? How does one become editor of a textbook? Editors are approached and appointed by the publishers, but of course publishers will take advice and soundings from within the...

Intratympanic steroids in Ménière's disease: what’s the evidence?

2 September 2022 | | ENTA - Audiology - Diagnostic, ENTA - Audiology - Adult, ENTA - Otology
The days of drastic surgery for Ménière's disease are long gone. We know that intratympanic injections can deliver high doses of medication to the inner ear with minimal discomfort and minimal risk. But how do we choose from the myriad...
Allergy journal cover image.

Biologicals for severe chronic rhinosinusitis with nasal polyps. Any use?

5 November 2021 | | ENTA - Rhinology / Sinus | chronic rhinosinusitis, dupilumab, mepolizumab, omalizumab, reslizumab
Recent advances and knowledge of inflammatory endotypes of chronic rhinosinusitis with nasal polyps (CRSwNP) led to introduction of biological agents such as monoclonal antibodies targeting IgE (omalizumab) and Interleukins (ILs) such as IL4R alpha (dupilumab) and IL5. The European Academy...

In conversation with Lawrence Cleary

1 May 2019 | | ENTA - Audiology - Adult, ENTA - Audiology - Paediatric, ENTA - Audiology - Auditory Implants, ENTA - Otology
Lawrence Cleary is an art dealer and an ENT patient. He is also a recipient of an MBE for his contribution towards establishing the first multichannel cochlear implant programme in the UK. In this article he discusses with Katherine Conroy...

New sites needed for STARFISH trial

26 February 2025
The STARFISH Trial is aiming to recruit 525 participants with sudden hearing loss from 75 ENT departments treating idiopathic sudden sensorineural hearing loss (ISSNHL).

In conversation with Jane Lea: the journey from athlete to surgeon

8 January 2024 | | ENTA - General
Dr Jane Lea is a clinical professor and fellowship director of otology and neurotology at the University of British Columbia. Prior to becoming a doctor, Jane was a semi-professional footballer and represented Canada. As a result of three knee operations,...

In conversation with Jane Lea: the journey from athlete to surgeon

8 January 2024 | | ENTA - ENT
Dr Jane Lea is a clinical professor and fellowship director of otology and neurotology at the University of British Columbia. Prior to becoming a doctor, Jane was a semi-professional footballer and represented Canada. As a result of three knee operations,...

In conversation with Vinidh Paleri, BACO International 2018 Academic Committee Lead

1 January 2018 | | ENTA - ENT
Vin Paleri has a central role in BACO International 2018 as the lead of the Academic Committee. Declan Costello caught up with him to discuss the role, and the most academically exciting aspects of the meeting. What is the international...

Tackling information overload and retention – interactive multimedia videos for first-time hearing aid users

1 November 2014 | | ENTA - Audiology - Adult
If you are an audiologist reading this article, how confident are you that all the information and advice that you offer your first-time hearing aid (HA) patients is understood, absorbed and then acted upon once they leave the comfort of...

New treatment for chronic voice disorders

30 March 2026
A new regenerative treatment for people with chronic voice disorders has been used in the UK for the first time. Guy’s and St Thomas’ is the first NHS trust in the country to provide this treatment in the larynx (or voice box) for patients with chronic voice conditions that cause voice change or dysphonia, making the voice sound hoarse, strained, breathy, weak, or fluctuate in pitch and loudness.